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We compared travel histories of case-patients with 
Cryptococcus gattii infection during 1999–2006 to travel 
destinations of the general public on Vancouver Island, 
British Columbia, Canada. Findings validated and reﬁ  ned 
estimates of risk on the basis of place of residence and 
showed no spatial progression of risk areas on this island 
over time.
C
ryptococcus gattii is a fungus that infects the lungs 
and central nervous system of mostly immunocompe-
tent humans and animals (1). In 1999, C. gattii emerged on 
the east coast of Vancouver Island (VI), British Columbia 
(BC), Canada (2), and is now considered endemic in the 
environment (3,4), affecting human (5) and animal popu-
lations (6). Travel histories of patients have been used to 
monitor fungal spread (5) and to estimate the incubation 
period of this disease (7,8).
Intra-island travel on VI is common, and fungal ex-
posure may not occur near residences of case-patients. 
Incidence rates calculated by using patient residence have 
suggested areas along the east coast of the island that may 
pose increased risk for infection (Figure) (9). Environmen-
tal sampling has provided evidence of the fungus over a 
large part of eastern VI. However, this sampling was not 
performed randomly and may not accurately identify areas 
of highest risk (3,4).
The Study
This study compared travel histories of C. gattii–in-
fected case-patients with travel patterns of the general pub-
lic to validate and reﬁ  ne these risk areas on VI. We also 
examined spatial progression of these areas over time to 
assess whether C. gattii spread from a single focal point 
since its emergence in 1999.
C.  gattii–infected case-patients were deﬁ  ned as BC 
residents with culture-conﬁ  rmed  C.  gattii infection or 
HIV-negative residents of BC with Cryptococcus sp. in-
fection diagnosed by antigen detection or histopathologic 
analysis. Analysis included all cases diagnosed from Janu-
ary 1999 through December 2006 in which the patient had 
documented travel history on VI. Case-patients were inter-
viewed by using a standard questionnaire and asked about 
travel to any city outside their city of residence in the 12 
months before symptom onset or diagnosis (8).
Tourism BC (www.hellobc.com/en-CA/default.htm) 
provided aggregated monthly visitor volume to 14 visitor 
centers in major tourist destinations (Figure) on VI during 
2000–2006. Visitors were counted if they spoke with visi-
tor center counselors. Only visitors classiﬁ  ed as BC resi-
dents were included in these analyses; additional personal 
attributes of visitors were not collected (C. Jenkins, pers. 
comm.). Seasonal visitor centers that had only partial data 
available for certain months were excluded.
Proportion of visits to each visitor center city was de-
ﬁ  ned as number of visits to a visitor center city divided by 
total number of visits to all visitor center cities. For case-
patients, the proportion was similarly deﬁ  ned. In both in-
stances, visits to multiple cities by the same person were 
counted multiple times. Differences between proportion 
of case-patient visits and Tourism BC visits were evalu-
ated by Fisher exact test and StatXact software (Cytel Inc., 
Cambridge, MA, USA). Analysis was conducted for all 
years combined and in 2 four-year increments (1999–2002 
and 2003–2006) to assess potential spread of C. gattii on 
VI over time. Because Tourism BC visitor data were un-
available for 1999, case data for 1999–2002 were com-
pared with aggregated Tourism BC visitor data from 2000 
through 2002. Analysis was also conducted for a subset of 
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Figure. Annual rate of infection with Cryptococcus gattii by local 
administrative area, 1999–2006 (9), and distribution of visitor center 
cities on Vancouver Island, British Columbia (BC), Canada. Only 
visitor centers that were included in the analysis are shown.case-patients who resided on the mainland because they 
represented travel exposures uncontaminated by potential 
exposure in place of residence. The α value for signiﬁ  cance 
was adjusted to account for testing multiple visitor center 
cities (p = 0.05/14 visitor center cities = 0.0036). Maps 
were created by using ArcMap version 8.2 (Environmental 
Systems Research Institute Inc., Redlands, CA, USA).
Travel history data were available for 104 (60.1%) 
case-patients. Eighty-two (78.8%) had traveled to >1 visi-
tor center city. Of these, 62 (75.6%) resided on VI and 20 
(24.4%) lived on the BC mainland. A signiﬁ  cantly greater 
proportion of visits to Parksville (18.7% vs 7.2%; p<0.0001) 
and Nanaimo (21.4% vs 7.4%; p<0.0001) were reported for 
patients than for Tourism BC visitors (Table). Similar re-
sults were obtained when analysis was restricted to earlier 
(1999–2002) and later (2003–2006) periods (Table).
When analysis was restricted to data concerning main-
land residents (patients with travel-associated exposure but 
no residential exposure to the fungus), a greater propor-
tion of mainland case-patients visited Courtenay (19.4% vs 
7.6%; p = 0.017), Parksville (30.6% vs 8.3%; p = 0.0001), 
Nanaimo (11.1% vs 6.9%; p = 0.313), and Qualicum Beach 
(8.3% vs 4.7%; p = 0.239) than did Tourism BC visitors 
during 1999–2006; however, only Parksville reached sta-
tistical signiﬁ  cance. Because of the small number of pa-
tients who resided on the mainland (n = 20), we could not 
further restrict this subset analysis to earlier (1999–2002) 
and later (2003–2006) periods.
Residents of VI may be exposed in their place of resi-
dence, in addition to their travel destination. However, we 
could not accurately weight patient exposure in the home en-
vironment to exposure at the travel destination. Minor differ-
ences in results obtained for all case-patients compared with 
only mainland patients may be caused by this limitation or 
by differences in travel preferences between these groups.
Although travel history data were unavailable for 
39.9% of the case-patients, they were not signiﬁ  cantly dif-
ferent in terms of mean age (p = 0.303, by F test) or sex 
(p = 0.574, by χ2 test). A higher proportion of included 
patients resided in central VI. However, travel patterns of 
central VI residents did not differ from travel patterns of 
other VI residents (data not shown). Our analysis assumes 
that travel patterns of Tourism BC visitors represent those 
of the general BC public. However, characteristics and 
activities of persons who use Tourism BC visitor centers 
may differ from those of persons who do not. Therefore, 
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Table. Proportion of cases of Cryptococcus gattii infection compared with proportion of BC residents who visited Tourism BC visitor 
centers, by location, Vancouver Island, British Columbia, Canada, 1999–2006* 
1999–2002 2003–2006 All years 
Location
No. (%) 
cases
No. (%) 
visits 
%
Difference
No. (%) 
cases
No. (%) 
visits 
%
Difference
No. (%) 
cases
No. (%) 
visits 
%
Difference
Nanaimo 26 (20.3) 20,160
(6.5)
13.8† 14 (23.7)  35,169
(8.0)
15.7† 40 (21.4)  55,329
(7.4)
14.0†
Parksville 25 (19.5)  24,095
(7.8)
11.8† 10 (16.9)  30,070
(6.9)
10.1 35 (18.7)  54,165
(7.2)
11.5†
Duncan 12 (9.4) 20,484
(6.6)
2.8 4 (6.8)  25,973
(5.9)
0.9 16 (8.6)  46,457
(6.2)
2.3
Victoria 24 (18.8) 58,092
(18.8)
0 16 (27.1)  94,452
(21.6)
5.6 40 (21.4)  152,544
(20.4)
1.0
Qualicum Beach  8 (6.3)  14,197
(4.6)
1.7 3 (5.1)  26,429
(6.0)
0.9 11 (5.9)  40,626
(5.4)
0.4
Port McNeill  1 (0.8)  5,985
(1.9)
1.2 0 6,378
(1.5)
1.5 1 (0.5)  12,363
(1.7)
1.1
Courtenay 8 (6.3) 35,051
(11.3)
5.1 4 (6.8)  30,859
(7.0)
0.3 12 (6.4)  65,910
(8.8)
2.4
Saltspring Island  4 (3.1)  19,093
(6.2)
3.0 1 (1.7)  20,744
(4.7)
3.0 5 (2.7)  39,837
(5.3)
2.7
Chemainus 3 (2.3) 13,374
(4.3)
2.0 1 (1.7)  23,273
(5.3)
3.6 4 (2.1)  36,647
(4.9)
2.8
Port Alberni  4 (3.1)  23,466
(7.6)
4.5 4 (6.8)  30,760
(7.0)
0.2 8 (4.3)  54,226
(7.3)
3.0
Sooke 3 (2.3) 15,450
(5.0)
2.6 0 19,485
(4.4)
4.4 3 (1.6)  34,935
(4.7)
3.1
Alert Bay  0 7,891
(2.5)
2.5 0 18,107
(4.1)
4.1 0 25,998
(3.5)
3.5†
Campbell River  8 (6.3)  29,219
(9.4)
3.2 2 (3.4)  49,830
(11.4)
8.0 10 (5.3)  79,049
(10.6)
5.2
Port Hardy  2 (1.6)  23,106
(7.5)
5.9 0 26,616
(6.1)
6.1 2 (1.1)  49,722
(6.6)
5.6†
All centers  128 309,663 –  59 438,145 –  187 747,808 –
*Visitor centers that were only opened seasonally were not included in the analysis. BC, British Columbia. 
†Significant differences after adjustment for multiple comparisons according to Fisher exact test (p<0.0036).  Tourism and C. gattii, Vancouver Island, Canada
caution is necessary when generalizing results to the entire 
BC population. Our interpretation is limited by its inability 
to account for duration of time spent in each visitor center 
city and speciﬁ  c activities of persons while there, factors 
that may contribute to exposure risk.
Conclusions
Our ﬁ  ndings suggest that the opportunity for C. gattii 
exposure in the areas studied has existed since the begin-
ning of its emergence and that minimal spatial progression 
of risk areas has occurred over time. Areas of higher risk 
near Parksville and Nanaimo are consistent with distribu-
tion of environmental samples, which shows a high num-
ber of C. gattii–positive samples in these areas (3). Results 
are also consistent with annual incidence rates for C. gattii 
infection based on place of residence, which are highest 
along the central eastern coast (Figure) (9).
When compared with areas on the basis of place of 
residence, more reﬁ  ned geographic risk areas associated 
with our analysis may result from potential reporting bias 
that produced reported percentage differences that are larg-
er than expected. BC residents may be more likely to visit 
or travel through Nanaimo, a commercial center on VI and 
transportation gateway to the rest of the island (10), than 
shown in Tourism BC data. Case-patients may be more 
likely to report traveling to Parksville, a popular tourist des-
tination, because it was often mentioned in media reports of 
the initial C. gattii outbreak. Alternatively, results may in-
dicate a true increase in travel-associated risk in areas near 
Parksville and Nanaimo. Some case-patients who resided 
in areas with high incidence rates may have acquired their 
infections by travel to these 2 areas. Although Parksville 
and Nanaimo may represent areas of higher risk, environ-
mental sampling suggests fungal colonization in southern 
and central eastern VI, and travelers can be exposed to C. 
gattii in these regions (3).
To determine travel-related risk for malaria (11) and 
gastrointestinal illness (12–14), travel patterns of case-pa-
tients have been compared with those of the general public. 
Use of visitor center information and tourism surveys is a 
cost-effective solution to derive comparison data during a 
retrospective investigation. This approach shows promise 
in assessing risk for environmental pathogens where loca-
tion of exposure is unclear.
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